APA

ter Braak B., Siezen C. L. E., Kannegieter N., Koedoot E., van de Water B. & van der Laan J. W. (20160506). Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel. : Archives of toxicology.

Chicago

ter Braak B, Siezen C L E, Kannegieter N, Koedoot E, van de Water B and van der Laan J W. 20160506. Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel. : Archives of toxicology.

Harvard

ter Braak B., Siezen C. L. E., Kannegieter N., Koedoot E., van de Water B. and van der Laan J. W. (20160506). Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel. : Archives of toxicology.

MLA

ter Braak B, Siezen C L E, Kannegieter N, Koedoot E, van de Water B and van der Laan J W. Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel. : Archives of toxicology. 20160506.